Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-01
DOI
10.3389/fphar.2020.00329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer
- (2018) ANTICANCER RESEARCH
- Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial
- (2018) Daiki Tsuji et al. SUPPORTIVE CARE IN CANCER
- Evaluation of Combination Antiemetic Therapy on CINV in Patients With Gynecologic Cancer Receiving TC Chemotherapy
- (2018) MOTOTSUGU SHIMOKAWA et al. ANTICANCER RESEARCH
- Patient-related Risk Factors for Nausea and Vomiting with Standard Antiemetics in Patients with Breast Cancer Receiving Anthracycline-based Chemotherapy: A Retrospective Observational Study
- (2018) Hitoshi Kawazoe et al. CLINICAL THERAPEUTICS
- Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study
- (2018) Toshinobu Hayashi et al. Cancer Management and Research
- Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan
- (2017) Yasushi Tsuji et al. EXPERT OPINION ON PHARMACOTHERAPY
- A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting
- (2017) Toshinobu Hayashi et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer
- (2016) Valentina E. Di Mattei et al. CANCER NURSING
- Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan
- (2016) Yoshifumi Baba et al. DISEASES OF THE ESOPHAGUS
- A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan
- (2016) Mika Mizuno et al. GYNECOLOGIC ONCOLOGY
- Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea
- (2016) Hiroyoshi Takemoto et al. International Journal of Clinical Oncology
- Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study
- (2016) Alexander Molassiotis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting
- (2016) Zhihuang Hu et al. MEDICINE
- Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients
- (2016) Sun Young Rha et al. SUPPORTIVE CARE IN CANCER
- Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan
- (2015) Kazuo Tamura et al. International Journal of Clinical Oncology
- Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
- (2015) Hirotoshi Iihara et al. International Journal of Clinical Oncology
- Pharmacogenetics of chemotherapy-induced nausea and vomiting
- (2015) Shigekazu Sugino et al. PHARMACOGENOMICS
- Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy
- (2014) Takeshi Kitazaki et al. SUPPORTIVE CARE IN CANCER
- Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin
- (2013) Naoto Furukawa et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis
- (2013) Ikuo Sekine et al. CANCER SCIENCE
- International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): Content and implementation in daily routine practice
- (2013) Karin Jordan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prognostic factors for chemotherapy induced nausea and vomiting
- (2013) David Warr EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
- (2013) Alexander Molassiotis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer
- (2013) Michiyasu Murakami et al. SUPPORTIVE CARE IN CANCER
- Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting
- (2013) A. Molassiotis et al. SUPPORTIVE CARE IN CANCER
- Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting
- (2012) N. Bouganim et al. Current Oncology
- Computational Prediction of State Anxiety in Asian Patients With Cancer Susceptible to Chemotherapy-Induced Nausea and Vomiting
- (2012) Kevin Yi-Lwern Yap et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antiemetic Effectiveness and Nausea and Vomiting Incidence During Capecitabine and Oxaliplatin Chemotherapy
- (2012) Alexandre Chan et al. NURSING RESEARCH
- Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting
- (2012) Gerald M. Higa et al. SUPPORTIVE CARE IN CANCER
- Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials
- (2012) Luigi Celio et al. SUPPORTIVE CARE IN CANCER
- Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer
- (2012) Stewart B. Fleishman et al. Journal of Oncology Practice
- Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy
- (2011) Jason M. Jones et al. JOURNAL OF PALLIATIVE MEDICINE
- Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study
- (2011) Doranne L. Hilarius et al. SUPPORTIVE CARE IN CANCER
- Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy
- (2010) David G. Warr et al. SUPPORTIVE CARE IN CANCER
- Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population
- (2010) Amin Haiderali et al. SUPPORTIVE CARE IN CANCER
- Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
- (2009) Vivianne Shih et al. ANNALS OF PHARMACOTHERAPY
- Insight in the prediction of chemotherapy-induced nausea
- (2009) Joseph A. Roscoe et al. SUPPORTIVE CARE IN CANCER
- Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy
- (2009) Paul J. Hesketh et al. SUPPORTIVE CARE IN CANCER
- How do patient expectancies, quality of life, and postchemotherapy nausea interrelate?
- (2008) Ben Colagiuri et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search